Therefore, our data allude to a model in which an NAFLD-inducible transcriptional complex composed of AP-1 and BRG1 activates the transcription of multiple downstream target genes to orchestrate NAFLD pathogenesis. Here, SMARCA4 is linked to metabolic dysfunction-associated steatotic liver disease.